SCHEMBL734345

SCHEMBL734345

CN(C)C1(Cc2ccccc2)CCC(c2[nH]c3ccccc3c2CCCO)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.46
KDM4E B2RXH2 2/20 0.46
OPRM1 P35372 4/20 0.44
OGFRL1 Q5TC84 1/20 0.44
ALDH1A1 P00352 3/20 0.41
HTT P42858 2/20 0.39
TSHR P16473 1/20 0.39
OPRL1 P41146 3/20 0.38
OPRK1 P41145 1/20 0.38
SIGMAR1 Q99720 2/20 0.36
HTR6 P50406 1/20 0.35
MAPT P10636 2/20 0.35
MCL1 Q07820 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
VDR P11473 1/20 0.35
CYP3A4 P08684 2/20 0.35
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3939479 0.90 OPRM1 (0.44) POLBKDM4EOPRM1OGFRL1ALDH1A1
SCHEMBL736057 0.89 EGFR (0.47) POLBKDM4EOPRM1OGFRL1ALDH1A1
SCHEMBL733093 0.88 OPRM1 (0.46) POLBKDM4EOPRM1OGFRL1ALDH1A1
Hydrochloric Acid SCHEMBL734749 0.88 EGFR (0.46) POLBKDM4EOPRM1OGFRL1ALDH1A1
SCHEMBL734445 0.87 OPRM1 (0.48) POLBKDM4EOPRM1OGFRL1ALDH1A1
SCHEMBL733587 0.86 OPRM1 (0.39) POLBKDM4EOPRM1OGFRL1ALDH1A1
SCHEMBL736265 0.85 KDM4E (0.46) POLBKDM4EOPRM1ALDH1A1HTT
Hydrochloric Acid SCHEMBL734975 0.85 OPRM1 (0.39) POLBKDM4EOPRM1OGFRL1ALDH1A1
Hydrochloric Acid SCHEMBL734205 0.84 KDM4E (0.45) POLBKDM4EOPRM1ALDH1A1HTT
SCHEMBL735109 0.84 OPRM1 (0.42) POLBOPRM1OGFRL1ALDH1A1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP claimed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US claimed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US claimed
EP-2044016-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2009-04-08 EP claimed
WO-2008009415-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1- AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2008-01-24 WO claimed
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
EP-2044016-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2009-04-08 EP disclosed
WO-2008009415-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1- AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 POLB 3818/4885KDM4E 2643/4885OPRM1 1029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.